Mesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-α levels

Abstract

BackgroundProgression of neurodegenerative diseases occurs when microglia, upon persistent activation, perpetuate a cycle of damage in the central nervous system. Use of mesenchymal stem cells (MSC) has been suggested as an approach to manage microglia activation based on their immunomodulatory functions. In the present study, we describe the mechanism through which bone marrow-derived MSC modulate the proliferative responses of lipopolysaccharide-stimulated BV2 microglia.MethodsBV2 microglia were cultured with MSC and stimulated with 1 μg/ml lipopolysaccharide. Using an inducible nitric oxide synthase inhibitor, tritiated thymidine (3H-TdR) incorporation assay was performed to determine the role of nitric oxide in the anti-proliferative effect of MSC. We also studied apoptosis and the cell cycle of both cell types using flow cytometry and explored their cytokine profile using protein and cytometric arrays. Moreover, the role of IL-6 and TNF-α in immunomodulation was deduced using specific blocking antibodies and recombinant proteins.ResultsMSC reduces microglia proliferation upon lipopolysaccharide stimulation by 21 to 28% and modulates the levels of nitric oxide, IL-6 and TNF-α. The role of nitric oxide in conferring the anti-proliferative effect of MSC was ruled out. Furthermore, we found that MSC exert their anti-proliferative effect by restoring the percentage of BV2 cells at S and G2/M phase to levels similar to unstimulated cells. MSC undergo a G0/G1 arrest while exerting this effect. We have also identified that MSC-mediated modulation of microglia is independent of IL-6, whilst reduction of TNF-α in co-culture is critical for inhibition of microglia proliferation.ConclusionsOur study demonstrates that MSC inhibit microglia proliferation independent of nitric oxide and IL-6, although reduction of TNF-α is critical for this effect. The inhibition of proliferation is through cell cycle modulation. These findings shed light on the mechanisms of microglial immunomodulation by MSC.Electronic supplementary materialThe online version of this article (doi:10.1186/s12974-014-0149-8) contains supplementary material, which is available to authorized users.

Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization

“…Increased proliferation rate of microglia by LPS, as we obtained in N9 cells based on the nuclear appearance of the Ki-67 marker and upregulation of Cd11b expression, was previously noticed in BV2-stimulated microglia [64]. Nevertheless, in vivo data do not sustain the presence of proliferating microglia during systemic inflammation [65], though it was evidenced during ischemia [66].…”

Human-derived normal mesenchymal stem/stromal cells in anticancer therapies

“…Recently, glioma pericytes were shown to switch from a tumor-suppressive phenotype to a tumor-promoting one in a xenograft model. The antiproliferative effect of MSCs also affects microglia cells by reducing the level of tumour necrosis factor-α 56. MSCs isolated from tumors showed immunosuppressive properties and can downregulate the activating NK cell receptors and impair tumor lysis by NK cells in vitro 57.…”

Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection

“…Following these seminal studies, the immunomodulatory effects of MSCs on circulating adaptive, as well as innate, immune cells have been extensively studied [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29]. In vitro, MSCs affect also the behavior of CNS cells such as microglial cells, and particularly inhibit microglial proliferation and their release of proinflammatory molecules; more specifically, MSCs induce the release of neuroprotective molecules by microglia and increase their phagocytic capability through the release of soluble factors [30][31][32][33][34][35]. Similarly, MSCs are able to skew the phenotype of macrophages from M1 to M2 type [36] [37].…”